SEC Filings

Form 424B5
CLOVIS ONCOLOGY, INC. filed this Form 424B5 on 06/21/2017
Document Outline
Entire Document (380 KB)
Subdocument 1 - 424B5 - 424B5 - FINAL
Page 1 - Filed pursuant to Rule 424(b)(5)
Page 2 - Prospectus Supplement
Page 3 - TABLE OF CONTENTS
Page 4 - ABOUT THIS PROSPECTUS SUPPLEMENT
Page 5 - WHERE YOU CAN FIND MORE INFORMATION
Page 6 - INCORPORATION BY REFERENCE
Page 7 - PROSPECTUS SUPPLEMENT SUMMARY
Page 8 - www.clovisoncology.com
Page 9 - Efficacy Data
Page 10 - Exploratory Endpoint of Response Rate:
Page 11 - N/A
Page 12 - THE OFFERING
Page 13 - N/A
Page 14 - RISK FACTORS
Page 15 - CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 16 - N/A
Page 17 - USE OF PROCEEDS
Page 18 - CAPITALIZATION
Page 19 - N/A
Page 20 - PRICE RANGE OF COMMON STOCK
Page 21 - DILUTION
Page 22 - N/A
Page 23 - DESCRIPTION OF CAPITAL STOCK
Page 24 - Registration Rights
Page 25 - No Stockholder Action by Written Consent
Page 26 - Transfer Agent and Registrar
Page 27 - MATERIAL U.S. FEDERAL INCOME AND ESTATE TAX CONSIDERATIONS
Page 28 - Dividends
Page 29 - Backup Withholding and Information Reporting
Page 30 - UNDERWRITING
Page 31 - N/A
Page 32 - Notice to Prospective Investors in the European Economic Area
Page 33 - Notice to Prospective Investors in the United Kingdom
Page 34 - Notice to Prospective Investors in Switzerland
Page 35 - Notice to Prospective Investors in Japan
Page 36 - Notice to Prospective Investors in China
Page 37 - LEGAL MATTERS
Page 38 - Prospectus
Page 39 - TABLE OF CONTENTS
Page 40 - ABOUT THIS PROSPECTUS
Page 41 - WHERE YOU CAN FIND MORE INFORMATION
Page 42 - INCORPORATION BY REFERENCE
Page 43 - CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS
Page 44 - ABOUT CLOVIS
Page 45 - RISK FACTORS
Page 46 - USE OF PROCEEDS
Page 47 - DILUTION
Page 48 - DESCRIPTION OF CAPITAL STOCK
Page 49 - Registration Rights
Page 50 - No Stockholder Action by Written Consent
Page 51 - Transfer Agent and Registrar
Page 52 - PLAN OF DISTRIBUTION
Page 53 - N/A
Page 54 - N/A
Page 55 - LEGAL MATTERS
Page 56 - 3,409,091 shares